Over one third of reproductive age women are obese, and this marked prevalence is impacting pregnancy. Obese women face many challenges from preconception to postpartum. They are at increased risk for both maternal and fetal complications including gestational diabetes, hypertension, preeclampsia, congenital anomalies, stillbirth, fetal macrosomia, cesarean delivery, venous thromboembolism, wound complications, breast-feeding difficulty, postpartum depression, postpartum weight retention, and neonatal death. This discussion is designed to help clinicians understand how obesity affects pregnancy, how to counsel patients regarding gestational weight gain, and how to implement management strategies during pregnancy to optimize health outcomes for these patients.
Obesity in the United States has increased significantly over the past few decades. Today >35% of all reproductive age women are obese [body mass index (BMI) Z30], and 8% are extremely obese (BMIZ40). 1 Although the prevalence of obesity has remained relatively constant since 1999, rates of obesity among non-Hispanic black women and Mexican American women continue to increase, 1 and these populations are often at highest risk for medical complications associated with obesity.
The World Health Organization categorizes obesity into 3 classifications on the basis of BMI. Obese class I is a BMI of 30 to 34.9, class II is a BMI of 35 to 39.9, and class III is a BMIZ40. 2 All classes of obesity are associated with multiple medical problems outside of pregnancy, including diabetes, cardiovascular disease, hyperlipidemia, hypertension, and obstructive sleep apnea, but likewise confer a risk across gestation.
The obesity epidemic is impacting pregnancy. Over half of all women entering pregnancy are either overweight or obese. 3 Causes for maternal obesity are complex and multifactorial. Societal factors such as lack of knowledge regarding nutrition, lack of access to healthy foods, and limited opportunities for physical activity have negative impacts on maternal and fetal well-being. Living >4 miles from a supermarket, for example, doubles the likelihood of having the lowest quartile of food quality, 4 which is associated with adverse birth outcomes. Mothers living near markets without fresh produce and dairy products are at higher risk for delivering low-birth weight infants. 5 Appreciating environmental and societal influences undoubtedly informs the practice of counseling obese women.
Overweight and obese women are at increased risk for several maternal and fetal complications including gestational diabetes, hypertension, preeclampsia, preterm birth, congenital anomalies, stillbirth, fetal macrosomia, cesarean delivery, venous thromboembolism (VTE), wound complications, breast-feeding difficulty, postpartum depression, postpartum weight retention, and neonatal death. 6 Although caring for obese women can pose a challenge to obstetric providers, understanding how obesity affects pregnancy and how to manage obese women throughout pregnancy, delivery, and the postpartum period optimizes health outcomes for these patients.
Maternal and Fetal Impacts of Obesity During Pregnancy
Several studies demonstrate an association between maternal obesity and adverse pregnancy outcomes. A large prospective multicenter study showed that women with a BMIZ30 had an increased risk for gestational diabetes mellitus, gestational hypertension, cesarean delivery, and fetal macrosomia compared with nonobese women (Table 1) . 7 Furthermore, severity of disease, especially preeclampsia, increases with higher BMI, making those with class II and III obesity at highest risk for complications. 8 The data regarding an association between obesity and preterm birth is conflicting. In a large European cohort the rate of preterm birth was increased, 9 whereas other studies found fewer preterm births and in fact more late-term and postterm pregnancies among obese women. [10] [11] [12] It has been suggested that preterm births among obese women are not spontaneous deliveries rather indicated deliveries related to maternal medical conditions. 11 Obesity also affects the fetus. The associated fetal risks include congenital anomalies, stillbirth, macrosomia, and long-term implications such as childhood obesity and type II diabetes mellitus. Obese women are more likely to deliver an infant with a congenital anomaly. 13 The risk of gastroschisis, however, is less among obese women (OR 1.70; 95% CI, 0.10-0.30). 13 Sonographic detection of congenital anomalies is diminished as performing ultrasounds on obese women is more difficult. 14 Visualization of fetal structures in the second trimester in obese women is reportedly decreased between 30% and 50%. [14] [15] [16] As obese women have an increased risk for neural tube defects, the Centre for Maternal and Child Enquiries and the Royal College of Obstetricians and Gynaecologists recommend supplementation with 5 mg of folic acid for women with a BMIZ30. 17 A large meta-analysis showed an increased OR for neural tube defect in obese (OR 1.70; 95% CI, 1.34-2.15) and severely obese women (OR 3.11; 95% CI, 1.75-5.46). 18 Epidemiologic studies have shown that obese women compared with normal weight women are less likely to use nutritional supplements or have adequate folic acid in their daily diets. Even controlling for folate intake, women with BMIZ27 had lower serum folate concentrations than women with a BMI of <27. 19 In the United States, most clinicians continue to recommend standard folic acid supplementation of 400 mg daily for preconception and early pregnancy.
Intrauterine fetal demise (IUFD) is more prevalent among obese women. There is a reported 3-fold increase of IUFD in women with a BMIZ35 (OR 3.90; 95% CI, 2.44-6.22). 10 Another large study of 24,000 women demonstrated a higher rate of IUFD and postnatal death despite controlling for antepartum complications. 20 Currently, it is unclear whether this increased rate of IUFD warrants routine antepartum testing in this population, particularly given the proportion of affected women and the associated economic costs and logistical considerations.
Finally, multiple studies have shown an association between prepregnancy obesity and excessive gestational weight gain (GWG) with fetal macrosomia. Maternal obesity and excessive GWG is thought to cause maternal insulin resistance and glucose intolerance, which increase fetal glucose, insulin, steroids, and growth hormones resulting in fetal fat deposition, accelerated birth weights, and childhood obesity. 21 In a secondary analysis of the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) trial, 13.6% of nondiabetic obese women developed macrosomia ( >4000 g birth weight) compared with 6.7% of nonobese normal weight women. 22 Furthermore, macrosomic infants born to obese women are more likely to have hyaline membrane disease (OR 2.14; 95% CI, 1.73-2.66), extended assisted ventilation (OR 1.71; 95% CI, 1.44-2.04), birth injury (OR 1.58; 95% CI, 1.37-1.84), and meconium aspiration (OR 1.42; 95% CI, 1.09-1.89). 23 The consequences of being born to an obese mother and being macrosomic persist after delivery. Large-forgestational age (LGA) infants have a 2-fold increased risk for metabolic syndrome as children (hazard ratios LGA 2.15; 95% CI, 1.25-3.82; maternal obesity 1.81; 95% CI, 1.03-3.19). 24 
A Clinician's Approach to Discussing Obesity in Pregnancy
Pregnancy is a special time in which patients have consistent and frequent interaction with health care providers. During prenatal visits advice from a physician can serve as a catalyst for change in patient behavior, 25, 26 and studies have shown that patients counseled on the benefits of healthy eating and physical activities are more likely to engage in these practices. 27 To inspire lifestyle changes in overweight and obese patients, physicians must tactfully and supportively address obesity.
Successfully managing a patient's weight in pregnancy includes the following steps: determining the patient's readiness to manage weight, setting a weight
The Clinical Approach to Obesity in Pregnancy 487 gain goal in pregnancy, framing the issue, prescribing healthy eating and physical activity behaviors, and following up with the patient at each visit ( Table 2) . When discussing obesity, clinicians should avoid using words with negative connotations and instead select more neutral phrases ( Table 3) .
To determine a patient's readiness to manage her weight, clinicians should simply ask straightforward, empathetic, and open-ended questions. This approach facilitates discussion about GWG, maternal obesity, and the associated risk factors. At the first prenatal visit clinicians should review with patients the guidelines for It is important to put into context for the patient how obesity and excessive GWG affects not only the pregnancy but longterm health. Clinicians should discuss associated maternal and fetal consequences of obesity. Although some patients might find these potential outcomes worrisome, clinicians can reassure the patient that risks can be minimized through appropriate prenatal care and management.
Once patient readiness has been determined, weight gain goals have been set, and the issue has been framed, clinicians should then counsel the patient about how to achieve lifestyle changes. It helps to give specific and clear advice. Clinicians should discuss with patients specific physical activities that are safe in pregnancy (such as walking, swimming, aerobics, cycling, and running), as well as those that should be avoided or activities with a high risk for trauma (such as scuba diving or skiing). Patients should also be counseled on the benefits of physical activity, including reduction in back pain, constipation, bloating, swelling, increase in energy, improved mood, muscle strength, flexibility, and endurance. Using phrases such as ''I strongly encourage you to'' may provide patients with motivation to make any needed changes.
Finally, clinicians need to followup with the patient at every visit regarding their health status. While patients should appreciate the importance of weight management, it is essential that they also understand that the clinicians' interest in their health is not dependent on their success in achieving weight goals. Clinicians should review with the patient what food choices they are making, what physical activity they are doing, and how they feel about their GWG. If needed, clinicians should provide the patient with good resources on healthy diet and exercise. An excellent and free online resource on nutrition and physical activity, for example, is MyPlate, a nutrition guide from the United States Department of Agriculture (http://www.choosemyplate.gov/).
Clinicians should also consider reviewing weight gain charts ( Fig. 1 ), which can be printed and given to the patient to track her GWG. When reviewing weight, discussing setbacks in weight management goals should be conducted in a supportive and nonthreatening manner.
Management of the Obese Woman During Pregnancy
Even though there are numerous complications associated with obesity during pregnancy, the goal of prenatal care should be to create an environment that emphasizes weight control, healthy nutrition, and physical activity while still monitoring for known risks to ensure a safe pregnancy. Obese women should feel comfortable discussing weight-related issues from preconception to postpartum (Table 4 ).
Preconception
Before conception is the ideal time to counsel an obese woman about her current health status and how it can impact her fertility and pregnancy. Obese women can significantly improve future pregnancies by optimizing their health status before conception. The Clinical Approach to Obesity in Pregnancy 489
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Less than half of providers address weight among overweight and obese women at annual examinations. 25 It is critical that BMI be documented at every visit, and that obese women receive counseling regarding weight reduction strategies. This may involve a structured weight loss plan, dietary modifications, or increased physical activity. Clinicians must be aware of community resources for patients and set realistic preconception weight loss goals. Although patients should try to lower their weight into a normal range, for many this is unobtainable. Instead, encouraging smaller weight loss goals such as 5% to 10% of their current weight or aiming for 1 BMI category lower may be more feasible and still provides positive health benefits.
In severely obese women or women with class II obesity with comorbidities it is reasonable to broach the subject of bariatric surgery. However, maternal age must be considered as the timeline to conception is delayed for a 6-month medically managed weight loss phase and at least a 6-month postoperative phase. These patients should also be screened for other medical conditions associated with obesity such as diabetes mellitus, hypertension, depression, and obstructive sleep apnea. If identified, these conditions should be treated and controlled before conception. Finally, all women contemplating pregnancy should be encouraged to take a folic acid supplement of 400 mg daily.
Bariatric Surgery
Women who have undergone bariatric surgery pose unique challenges for obstetrical management. Over 100,000 bariatric surgeries are performed annually in the United States with over half of these procedures occurring in reproductive aged women. For many women weight loss after bariatric surgery improves fertility and reduces the risk for diabetes, preeclampsia, and gestational hypertension. 28 
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The clinician must also be aware of the potential risks and how the type of surgery affects pregnancy. If a patient recently had bariatric surgery, delaying pregnancy in the rapid weight loss phase, which is usually >1 year, allows for maximum weight loss and adequate healing. 28 Malnutrition and small-for-gestational The Clinical Approach to Obesity in Pregnancy 491 age babies have been reported during this phase. 28 Gastric banding and Roux-en-Y procedures have less risk for malnutrition, compared with a biliopancreatic diversion. However, all patients with a history of bariatric surgery should be screened for nutritional deficiencies such as iron, folate, vitamin B 12 , vitamin D, and calcium. 6, 28 Screening and supplementation should be assessed every trimester and extended release medication avoided. Malabsorption may impair iron supplementation, and patients may require intravenous iron infusions to treat anemia. Women with dumping syndrome and some gastric bands may not tolerate a 50 g glucose tolerance test for assessment of gestational diabetes. The clinician instead can use alternate testing strategies for gestational diabetes such as fasting and 1-hour postprandial finger stick glucoses for 1 to 2 weeks at 24 to 28 weeks gestation or check a fasting blood glucose and hemoglobin A1c. 6 Women after bariatric surgery can have complications remote from the procedure. Each year more cases of pregnancy complications after bariatric surgery have been described including anastamotic leaks, obstruction, internal hernias, gastrointestinal bleeding, and erosion and migration of bands. 28 Clinicians should have a high index of suspicion for bariatric surgeryrelated complications in a woman who presents with abdominal pain. Consultation with a bariatric or general surgeon should be considered in these cases.
Exploratory surgery is more common in postbariatric surgery patients as often diagnosis is delayed. 28 
Antepartum
Once pregnancy is confirmed, a woman's height and weight should be collected and her BMI calculated. Early in pregnancy, GWG goals should be reviewed with the patient. In 2009, the Institute of Medicine (IOM) published new guidelines regarding GWG ( Table 5 ). 21 These guidelines specifically addressed those with a BMIZ30 recommending weight gain between 11 and 20 pounds.
The IOM also modified its recommendations for special populations. Women of short stature, adolescents, and all race/ ethnicities are encouraged to gain the standard amount on the basis of their prepregnancy BMI category. For twin gestation, the IOM advised a GWG of 37 to 54 pounds for normal weight women, 31 to 50 pounds for overweight women, and 25 to 42 pounds for obese women. 21 Excessive GWG is associated with increased birth weight and postpartum weight retention. 21 Even though the IOM recommends weight gain for women with BMIZ30, there is much debate on whether zero weight gain or even weight loss is safe for this population, and particularly for those with in the class II and III obesity. Studies have shown that zero weight gain and weight loss are associated with decreased rates of preeclampsia, cesarean 29, 30 In contrast, other studies including a large prospective analysis by Catalano et al 31 found higher rates of small-for-gestational age infants in women who lost weight or gained <5 kg (OR 2.6; 95% CI, 1.4-4.7; P = 0.003). Despite conflicting studies regarding the impact of inadequate weight gain in pregnancy, the American College of Obstetricians and Gynecologists (ACOG) now states that ''for an obese pregnant woman who is gaining less weight than recommended but has an appropriately growing fetus, no evidence exists that encouraging increased weight gain to conform with the updated IOM guidelines will improve maternal or fetal outcomes.'' 32 In a compassionate and caring way, the patient should be reminded of GWG goals throughout pregnancy, have their weight monitored, and receive positive and consistent feedback from all clinicians and ancillary staff. Serum genetic screening and first trimester sonographic screening should be encouraged, as second trimester ultrasound screening alone is less efficacious at detecting anomalies. 6 It is unclear whether fetal surveillance (NST/ AFI) for obese women is cost-effective; however, consideration should be made for antenatal testing in the severely obese as they are at greatest risk for IUFD.
The provider can implement simple strategies to make the clinical setting more hospitable to the obese patent. Although the following recommendations may seem straightforward and perhaps inconsequential, they set the stage for effective and compassionate communication ( Table 6 ). The office itself can be more comfortable by having benches or chairs without arm rests, as arm rests may be more constraining to overweight and obese women. A patient's weight should be considered a private matter, and having the scale in a private location allows the patient to feel more at ease. Large blood pressure cuffs should be available at each location where blood pressures are taken, as undersized cuffs can overestimate blood pressure. Finally, examination rooms should be equipped with larger gowns and sheets for patient use along with step stools to help patients get onto the examination table and longer speculums to perform comfortable pelvic examinations.
Pregnancy is an opportunity for all women to improve their nutritional status and physical activity. ACOG recommends pregnant women eat a balanced diet composed of the 5 major food groups (grains, fruits, vegetables, protein, and dairy) along with supplements of folic acid, vitamin D, calcium, and iron. 32 For physical activity, ACOG recommends that in the absence of either medical or obstetric complications, all pregnant women should engage in 30 minutes or more of moderate exercise per day on most, if not all, days of the week. 33 Physical activity, especially in the obese patient, has been shown to decrease the rate of gestational diabetes. 33 In general, however, women are not following these recommendations. Less than 2% of women aged 19 to 30 eat the recommended amounts of fruits and vegetables. Even when the requirement is lowered to the essential 5-a-day servings of fruits and vegetables, <30% of women aged 19 to 30 and <40% of women aged 31 to 50 meet targets. 34 Only 5% of adults meet the recommended 30 minutes of moderate physical activity per day, 5 days per week. 35 Although data in pregnancy are limited, DiNallo et al 35 reported that The Clinical Approach to Obesity in Pregnancy 493 www.clinicalobgyn.com <12% of women meet physical activity recommendations in pregnancy. This is despite more recent data supporting that moderate physical activity in pregnancy is not associated with preterm labor, low birth weight or pregnancy loss, and studies showing an inverse association between physical activity and GWG. 36 Acknowledging that most women are not physically active, initiation of physicial activity, particularly in obese women, should start with small achievable goals. Having patients walk 2 to 3 times per week for 10 minutes is a reasonable first goal. Afterward consider adding another 5 minutes of activity per session. Women should be advised to watch for symptoms of chest pain, contractions unrelieved by rest, vaginal bleeding, and loss of fluid. 33 Although causes for poor nutrition and lack of physical activity are multifactorial, clinicians should motivate patients to be more engaged in their health. Maternal-centered nutrional counseling, group exercise, and personalized health coaching are all examples of lifestyle interventions shown to decrease GWG in overweight and obese women. 37 However, these research interventions involve significant resources and time that may not be available to most clinicians. A simple and easy way to monitor a patient's health status is just to ask about her level of physical activity, her diet, and her GWG. If additional assistance is needed clinicians should consider referrals to nutritionists in early pregnancy and each trimester. In addition, physicians should refer patients to MyPlate (http://www.choosemyplate.gov/), which provides customized nutrition plans including plans based on trimester and breast-feeding.
All obese women should be screened early in pregnancy for gestational diabetes, as many women may have unidentified type II diabetes. Different testing options include hemoglobin A1c, fasting blood glucose, or glucose tolerance test. If screening is negative, follow-up testing should be performed between 24 and 28 weeks gestation. 38 Finally, determining the estimated fetal weight in an obese patient may be challenging closer to delivery. As these women are at increased risk for macrosomia and associated complications, having an accurate fetal weight is important for delivery planning. Studies have demonstrated that ultrasound may underestimate fetal weight especially in class III obese patients. 39 However, clinical estimates also perform poorly, so a sonographic assessment for estimated fetal weight at 36 to 37 weeks can have some utility in delivery planning in women with a BMIZ35.
Intrapartum
Labor and delivery in the obese woman requires a team approach including nursing staff, anesthesiologists, and obstetricians being actively involved in the patient's care. External fetal monitoring and tocometer use may be more difficult in these women because of their body habitus. Promising new fetal heart rate technologies such as the STAN monitor, Monica An24, MERIDIAN monitor, and EMG-based tocometers could improve the ability to detect nonhypoxic fetuses especially in obese women; however, they are not mainstream. 40 Tracing the fetal heart rate and contraction pattern may be more challenging and requires a proactive care team.
Anesthesiology should also be consulted early in the labor process. In women with a BMI>50, clinicians should consider an anesthesia consultation before the onset of labor. Epidural anesthesia is strongly recommended over general anesthesia, as a 1-cm increase in the neck circumference translates to a 1.13 increase in unsuccessful or complicated intubations. 41 Placing an early epidural gives the anesthesiologist more time to locate the necessary landmarks, which may be more difficult to find in the obese patient. Ultrasound guidance, which is being used with increased frequency, can decrease the placement time and number of attempts for neuraxial anesthesia. [42] [43] [44] The risk for cesarean delivery increases with BMI. The rate of cesarean delivery was 20.7% for women with a BMI<30 compared with 33.8% for women with a BMI of 30 to 34.9 and 47.4% for women with a BMI of 35 to 39.9. 7 Vaginal delivery should be the goal for all obese women in labor, unless contraindicated. Even though vaginal delivery is less morbid, it can still be complicated. In the obese patient, there are higher rates of operative delivery and risks for birth trauma from shoulder dystocia due to fetal macrosomia. 7 It is important that the clinician is aware of these possible complications during a vaginal delivery.
The success of vaginal birth after cesarean (VBAC) is also lower in obese women. Obese women are 50% less likely to have a successful VBAC. 45 In addition, women with excessive GWG of >40 pounds are 40% less likely to have a VBAC compared with those who gained <40 pounds (OR 0.63; 95% CI, 0.42-0.97). 45 Clinicians should modify their counseling regarding chance for successful VBAC in obese women. A useful tool is the Maternal-Fetal Medicine Units Network VBAC calculator (https:// mfmu.bsc.gwu.edu/PublicBSC/MFMU/ VGBirthCalc/vagbirth.html), which takes into account maternal BMI in determining chance of VBAC.
If a cesarean delivery is required anticipated complications include increases in operative time, blood loss, transfusions, length of stay, pressure sores, nerve injuries, deep vein thromboses, wound complications, difficult intubations, and associated pulmonary complications. 46 During a cesarean delivery, the surgeon should know the weight limit of the operating room table, and have sufficient staff or an air mattress lift device to properly move the patient. Higher dosing of preoperative antibiotics (2 g of cefazolin) should be administered in women with a BMIZ30 or weighing >220 pounds. 47 Placement of the abdominal incision can be difficult to determine in severely obese woman as the pannus tends to deviate the abdominal wall caudally. Locating the anterior superior iliac spines helps determine the incision location. A Pfannenstiel incision usually results in dissecting minimum subcutaneous adipose tissue. To optimize visualization of the lower abdomen the pannus may be retracted with tape or a surgical incise drape to the bar that resides at the patient's shoulders or across the breasts. However, if the pannus is unable to be elevated a vertical periumbilical and supraumbilical incision might be necessary. An intraoperatively flexible O-ring retractor along with longer instruments may be helpful. It is often not possible to exteriorize the uterus because of the pannus, thus in situ closure of the uterus may be necessary. Application of uterine fundal pressure may be required for delivery of the fetus. To place adequate pressure, disconnect the retraction bar or obtain assistance from the anesthesiologist.
To decrease wound breakdown and surgical site infection closure of the subcutaneous layer when >2 cm reduces the incidence of postoperative wound disruption. 48 Subcutaneous drains are not recommended as they have not been shown to decrease surgical site infection. Method for incision closure is also important. Figueroa and colleagues examined the risk for cesarean wound disruption or infection after closure with surgical staples compared with subcuticular suture, and found higher rates of composite wound disruption and infection at the time of hospital discharge and 4 to 6 weeks postpartum in the group closed with staples. There was no difference in pain control, cosmesis, or patient satisfaction between groups. 49 The Clinical Approach to Obesity in Pregnancy 495
Postpartum
Immediately after delivery, obese women are at risk for VTE formation. Cesarean delivery alone has been estimated to double the risk for VTE postpartum. 50 Along with early ambulation and sequential compression devices (SCDs), ACOG and the American College of Chest Physicians recommend clinicians consider prophylactic anticoagulation in women undergoing cesarean delivery. Options for VTE prevention include pneumatic compression devices and unfractionated heparin or low-molecular weight heparin. 50, 51 ACOG advocates individual risk assessment regarding VTE prevention. 50 American College of Chest Physicians recommends VTE prophylaxis on the basis of a risk calculation. Women with BMIZ30 and those who have undergone cesarean delivery are in the highest-risk category in which SCDs and unfractionated heparin or low-molecular weight heparin are advised. 51 The current recommended dosing for VTE prophylaxis is 40 mg of enoxaparin once daily. 51 Obesity alters the bioavailability and distribution of enoxaparin, and there is limited evidence as to the optimal dosing of enoxaparin in this population. In obese patients undergoing bariatric surgery, several studies have demonstrated insufficient levels of anti-Xa on once-daily doses. [52] [53] [54] [55] Various dosing recommendations have been studied in obese nonpregnant patients including 40 mg twice daily, 60 mg twice daily, and weight-based dosing (0.5 mg/kg twice daily). In a study by Borkgre-Okonek and colleagues in 2008, fixed dosing based on BMI was compared. In those receiving 40 mg twice daily 79% reached target prophylactic concentrations compared with 69% in those receiving 60 mg twice daily. None of the patients studied reached full anticoagulation state (anti-Xa level between 0.6 and 1.0), and there were no incidences of excessive bleeding or wound complications. 52 As a result of these studies clinicians may consider higher doses of prophylactic anticoagulation for the obese patient.
At our institution, we administer 40 mg of enoxaparin twice a day for women with a BMI between 40 and 59.9 and 60 mg twice a day for women with a BMIZ60. Another option would be weight-based dosing of 0.5 mg/kg twice a day. All patients on anticoagulation should be monitored for potential complications including bleeding, wound complications, and adverse drug reactions.
Wound complications including breakdown and infection are more common after cesarean delivery in obese women. In morbidly obese women (BMIZ50) a 30% wound complication rate has been reported. 56 Clinicians should instruct patients to keep their incision clean and dry. Placing gauze or pads over the incision can help keep it dry especially in patients with a large pannus. Patients may be unable to see their incision themselves, so instructing family members to look at the incision and keep it clean can help prevent infections. Having the patient return for a wound check 1 to 2 weeks after discharge allows for early identification of infections or breakdown.
Breast-feeding can be challenging for the obese woman. Several studies have demonstrated an association between obesity and breast-feeding failure even after controlling for socioeconomic status. 57, 58 Higher prepregnancy BMI is associated with shorter breast-feeding duration. 59 Unfortunately, both maternal obesity and short duration of breast-feeding are independent risk factors for overweight children. 58 Poor breast-feeding in the obese woman might be attributable to delayed lactogenesis. Higher prepregnancy BMI predicted a lower prolactin response to suckling at 48 hours postpartum. 59 The decreased responsiveness of prolactin could lead to diminished milk production and breast-feeding discontinuation. 59 Encouraging obese women before
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Overcash and LaCoursiere www.clinicalobgyn.com delivery to breast-feed and providing adequate lactation support postpartum might help their ability to breast-feed. Postpartum depression in all women is underdiagnosed, and obesity is a risk factor for depressed mood during pregnancy and postpartum. In a large study of >1000 women higher rates of postpartum depression was seen with increasing prepregnancy BMI. 60 The percentage of women screening positive for postpartum depression was 14.4% in normal weight women, 18% in underweight, 18.5% in overweight, 18.8% in obese class I, 32.4% in obese class II, and 40% in obese class III women. 60 BMIZ40 was strongly associated with depressive and anxiety symptoms, loss of control, perceived stress, restrained eating, dieting, and weight cycling. 61 Clinicians should screen and discuss with all women symptoms of postpartum depression and, if identified, initiate early treatment.
The most important goal postpartum should be minimizing postpartum weight retention. Significant postpartum weight retention is associated with long-term obesity and subsequent development of diabetes and heart disease. 62 Unfortunately, less than half of women attain their prepregnancy weight, and 26% retained >10 pounds 1 year after delivery. 63 At 6 weeks postpartum clinicians should examine their patient's weight and discuss with them weight loss strategies. Although many new mothers lack sleep and energy, encouraging them to eat healthy and exercise daily can improve their weight and energy level.
Recommendations
The obese woman is at higher risk for both maternal and fetal complications in pregnancy. However, with proper management and positive encouragement regarding GWG many of these risks can be minimized. Our key recommendations for the clinician managing the obese pregnant woman are as follows:
Every visit should create a comfortable, supportive, and safe environment to discuss healthy lifestyles with the patient;
Counseling regarding weight management should include determining the patient's readiness to manage weight, setting a weight gain goal in pregnancy, framing the issue, prescribing healthy eating and physical activity behaviors, and following up with the patient at each visit; Before conception all medical problems should be well controlled and patients should be encouraged to undergo a weight reduction program to minimize risks associated with prepregnancy obesity;
Complying with IOM GWG goals should be encouraged; however, recommending less than the IOM goals for an obese patient with an appropriately growing fetus is reasonable; Women should be provided specific nutritional and exercise advice with a referral to a nutritionist to optimize healthy food choices; Screening should be conducted early for gestational diabetes and other vitamin deficiencies such as B 12 The Clinical Approach to Obesity in Pregnancy 497 in minimal dissection of adipose tissue. To aid visualization of the lower abdomen, retracting the pannus with tape or a surgical incise drape should be considered. If a Pfannenstiel incision cannot be made safely, a vertical periumbilical and supraumbilical incision may be necessary; After cesarean delivery, consideration based on BMI at the time of delivery (Z40) should be given for prophylactic anticoagulation with either unfractionated heparin or low-molecular weight heparin along with SCDs and early ambulation for the prevention of VTE; Women should be seen 1 to 2 weeks after discharge for an incision check, assessment of breast-feeding status, and evaluation of mood; and At the postpartum visit, weight retention should be addressed and the patient referred to appropriate weight reduction programs.
